In previous work, it was determined that loss of the BIN1 (bridging integrator 1) tumor suppressor resulted in dysregulated induction of IDO1 in oncogenically transformed skin fibroblasts thereby facilitating immune escape when the cells were grafted into immune competent hosts (16). The gene discussed is BIN1; the disease is neoplasm.